Table 3 Clinical and laboratory characteristics at admission to the medical intensive care units in the overall population, nonsurvivors and survivors
All patients n = 76 | MICU survivors n = 40 | MICU nonsurvivors n = 36 | P value | |
|---|---|---|---|---|
SAPS II | 43 ± 16.5 | 40 ± 13 | 46 ± 19 | 0.14 |
Apache II | 22 ± 7.7 | 21 ± 6.8 | 23.5 ± 8.5 | 0.11 |
Blood cell count (/mm3) | 11616 ± 8688 | 12899 ± 9250 | 10226 ± 7931 | 0.18 |
Hemoglobin (g/dL) | 10.7 ± 2.2 | 10.5 ± 2.3 | 10.9 ± 2.2 | 0.4 |
Platelet count (x1000/mm 3 ) | 240 ± 236 | 304 ± 294 | 173 ± 126 | 0.016 |
Platelet count ≤ 100 000/mm 3, n (%) | 19 (25.7) | 4 (10.5) | 15 (41.7) | 0.002 |
Calcium (mmol/L), | 2.1 ± 0.1 | 2.11 ± 0.19 | 2.08 ± 0.24 | 0.54 |
Albumin (g/L) | 25 ± 6.4 | 27 ± 6 | 23 ± 6 | 0.14 |
Albumin ≤ 25 g/L, n (%) | 16 (51.6) | 4 (30.8) | 12 (66.7) | 0.05 |
PaO 2 /FiO 2 | 177 ± 102 | 201 ± 104 | 149 ± 93 | 0.05 |
Number of organ failures | 2 ± 1.2 | 1.7 ± 1 | 2.3 ± 1.3 | 0.036 |
Acute respiratory failure, n (%) | 66 (86.8) | 30 (75) | 36 (100) | 0.001 |
Mechanical ventilation, n (%) | 56 (73.7) | 23 (57.5) | 33 (91.7) | 0.001 |
NIV, n (%) | 17 (22.4) | 6 (15) | 11 (30.6) | 0.089 |
Invasive ventilation, n (%) | 50 (65.8) | 19 (47.5) | 31 (86.1) | <0.0001 |
Time on mechanical ventilation (days) | 9,8 ± 14 | 12 ± 17 | 8,5 ± 12,4 | 0.41 |
Need for vasoactive agents, n (%) | 25 (32.9) | 5 (12.5) | 20 (55.6) | <0.0001 |
Acute renal failure, n (%) | 26 (34.6) | 11 (27.5) | 15 (41.7) | 0.14 |
hemodialysis, n (%) | 7 (9.2) | 2 (5) | 5 (13.9) | 0.17 |
Neurological failure, n (%) | 16 (21.1) | 8 (20) | 8 (22.2) | 0.52 |
Chemotherapy in the ICU, n (%) | 4 (5.5) | 1 (2.7) | 3 (8.3) | 0.29 |
Corticosteroids in the ICU, n (%) | 7 (9.3) | 5 (12.5) | 2 (5.7) | 0.27 |